[go: up one dir, main page]

PA8591901A1 - Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b - Google Patents

Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b

Info

Publication number
PA8591901A1
PA8591901A1 PA20038591901A PA8591901A PA8591901A1 PA 8591901 A1 PA8591901 A1 PA 8591901A1 PA 20038591901 A PA20038591901 A PA 20038591901A PA 8591901 A PA8591901 A PA 8591901A PA 8591901 A1 PA8591901 A1 PA 8591901A1
Authority
PA
Panama
Prior art keywords
quinazolin
ona
derivatives
inhibitors
mao
Prior art date
Application number
PA20038591901A
Other languages
English (en)
Inventor
Sarmiento Rosa Maria Rodriguez
Andrew William Thomas
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8591901A1 publication Critical patent/PA8591901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION SE REFIERE A DERIVADOS DE LA 3H-QUINAZOLIN-4-ONA DEFINIDOS EN LA DESCRIPCION Y EN LAS REINVINDICACIONES, A UN PROCESO PARA SU OBTENCION, A COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y A SU UTILIZACION COMO INHIBIDORES SELECTIVOS DE LA MONOAMINA-OXIDASA B.
PA20038591901A 2002-12-13 2003-12-10 Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b PA8591901A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02027700 2002-12-13

Publications (1)

Publication Number Publication Date
PA8591901A1 true PA8591901A1 (es) 2004-11-26

Family

ID=32524001

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038591901A PA8591901A1 (es) 2002-12-13 2003-12-10 Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b

Country Status (23)

Country Link
US (1) US7087612B2 (es)
EP (1) EP1572666B1 (es)
JP (1) JP4384053B2 (es)
KR (1) KR100707532B1 (es)
CN (1) CN100418954C (es)
AR (1) AR042362A1 (es)
AT (1) ATE335729T1 (es)
AU (1) AU2003293798B8 (es)
BR (1) BR0317282A (es)
CA (1) CA2509633A1 (es)
CL (1) CL2003002565A1 (es)
DE (1) DE60307512T2 (es)
ES (1) ES2270154T3 (es)
GT (1) GT200300284A (es)
MX (1) MXPA05006124A (es)
MY (1) MY141743A (es)
PA (1) PA8591901A1 (es)
PE (1) PE20040911A1 (es)
PL (1) PL377474A1 (es)
RU (1) RU2340604C2 (es)
TW (1) TW200424180A (es)
UY (1) UY28120A1 (es)
WO (1) WO2004054985A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045096A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
RU2007129642A (ru) 2005-02-25 2009-03-27 Ф.Хоффманн-Ля Рош Аг (Ch) Таблетки с улучшенным распределением лекарственного вещества
WO2007016525A2 (en) 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
GB0525068D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
JP4876690B2 (ja) * 2006-04-21 2012-02-15 三菱瓦斯化学株式会社 キナゾリン−４−オン誘導体の製造法
EP2123627B1 (en) * 2007-01-19 2013-11-20 Ube Industries, Ltd. Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group
JP5236664B2 (ja) 2007-02-01 2013-07-17 レスバーロジックス コーポレイション 心血管疾患を予防および治療するための化合物
NZ586440A (en) 2008-06-26 2011-07-29 Resverlogix Corp Methods of preparing quinazolinone derivatives
EP2660238B1 (en) 2009-01-08 2015-05-06 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular disease
MX392179B (es) 2009-03-18 2025-03-21 Resverlogix Corp Nuevos agentes anti-inflamatorios.
AU2010239266B2 (en) 2009-04-22 2015-01-22 Resverlogix Corp. Novel anti-inflammatory agents
PT2773354T (pt) 2011-11-01 2019-07-17 Resverlogix Corp Formulações orais de libertação imediata para quinazolinonas substituídas
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
JP6903585B2 (ja) 2015-03-13 2021-07-14 レスバーロジックス コーポレイション 補体関連疾患の治療のための組成物および治療方法
CN106146410B (zh) * 2015-04-03 2018-10-12 中南大学 6-氨基-4(3h)-喹唑啉酮衍生物及其合成方法和用途
CN108191667B (zh) * 2018-01-04 2021-03-26 利尔化学股份有限公司 2-硝基-4-三氟甲基苯甲酸甲酯的制备方法
CN109553534A (zh) * 2018-11-27 2019-04-02 常州大学 一种2-硝基-4-甲氧基苯甲酸的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6136273A (ja) * 1984-07-26 1986-02-20 Mitsubishi Yuka Yakuhin Kk ２−フエニルアルキル−４（３ｈ）−キナゾリノン誘導体
WO1996028430A1 (en) * 1995-03-14 1996-09-19 Novartis Ag Trisubstituted phenyl derivatives
IL117659A (en) * 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
US5783577A (en) * 1995-09-15 1998-07-21 Trega Biosciences, Inc. Synthesis of quinazolinone libraries and derivatives thereof
JP3258027B2 (ja) 1996-03-15 2002-02-18 サマーセット・ファーマシューティカルズ・インコーポレイテッド セレジリン投与による末梢ニューロパシーの予防および治療方法
DE69838172T2 (de) * 1997-08-22 2008-04-10 Astrazeneca Ab Oxindolylchinazolinderivate als angiogenesehemmer
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
AU1359801A (en) 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
EP1572666B1 (en) 2006-08-09
PL377474A1 (pl) 2006-02-06
AU2003293798B2 (en) 2009-01-15
RU2005121908A (ru) 2006-01-27
KR100707532B1 (ko) 2007-04-12
CA2509633A1 (en) 2004-07-01
DE60307512D1 (de) 2006-09-21
EP1572666A1 (en) 2005-09-14
MY141743A (en) 2010-06-30
JP4384053B2 (ja) 2009-12-16
RU2340604C2 (ru) 2008-12-10
CN100418954C (zh) 2008-09-17
MXPA05006124A (es) 2005-08-16
ES2270154T3 (es) 2007-04-01
TW200424180A (en) 2004-11-16
CN1720237A (zh) 2006-01-11
DE60307512T2 (de) 2007-02-08
KR20050085587A (ko) 2005-08-29
JP2006513177A (ja) 2006-04-20
US7087612B2 (en) 2006-08-08
BR0317282A (pt) 2005-11-08
UY28120A1 (es) 2004-06-30
AU2003293798A1 (en) 2004-07-09
PE20040911A1 (es) 2004-12-11
AR042362A1 (es) 2005-06-15
US20040142951A1 (en) 2004-07-22
AU2003293798B8 (en) 2009-02-12
CL2003002565A1 (es) 2005-01-07
WO2004054985A1 (en) 2004-07-01
ATE335729T1 (de) 2006-09-15
GT200300284A (es) 2004-07-14

Similar Documents

Publication Publication Date Title
PA8591901A1 (es) Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b
PA8693101A1 (es) Compuestos de isoindol-imida y composiciones que los incluyen y mètodos para su uso
CR7828A (es) Oxialquilamidas de quinolina, isoquinolina y quinazolina y su uso como fungicidas
ECSP077271A (es) Derivados de pirimidina
CR10696A (es) Compuestos de n-metilaminometil isoindol, composiciones que las comprenden y metodos que utilizan los mismos
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
ECSP077259A (es) Derivados de pirimidina
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
HN2003000064A (es) Derivados de nicotinamida utiles como inhibidores de pde4
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
HN2003000114A (es) Derivados del tropano utiles en terapia
HN2006019066A (es) "(s)-n-metilnaltrexona"
PA8541601A1 (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7.
CR8858A (es) Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
UY29601A1 (es) Arilpirazoles sustituidos
CR9786A (es) Compuestos de bencimidazol-tiofeno
HN2006035237A (es) Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas
HN2006007884A (es) Derivados de oxiindol
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
PA8618901A1 (es) Biaril sulfonamidas y metodo para el uso de las mismas
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
PA8654701A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion